These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31605272)

  • 1. Serum albumin and risk of cardiovascular events in primary and secondary prevention: a systematic review of observational studies and Bayesian meta-regression analysis.
    Pignatelli P; Farcomeni A; Menichelli D; Pastori D; Violi F
    Intern Emerg Med; 2020 Jan; 15(1):135-143. PubMed ID: 31605272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic plaque characteristics are not associated with future cardiovascular events in patients undergoing iliofemoral endarterectomy.
    van Haelst STW; Haitjema S; Derksen W; van Koeverden I; de Vries JPM; Moll FL; den Ruijter HM; Pasterkamp G; de Borst GJ
    J Vasc Surg; 2018 Mar; 67(3):809-816.e1. PubMed ID: 29017805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Mahaffey KW; Neal B; Perkovic V; de Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR;
    Circulation; 2018 Jan; 137(4):323-334. PubMed ID: 29133604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.
    Kitas GD; Nightingale P; Armitage J; Sattar N; Belch JJF; Symmons DPM;
    Arthritis Rheumatol; 2019 Sep; 71(9):1437-1449. PubMed ID: 30983166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study.
    Gibson AO; Blaha MJ; Arnan MK; Sacco RL; Szklo M; Herrington DM; Yeboah J
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1108-15. PubMed ID: 25459592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia].
    Chen L; Han XD; Li YL; Zhang CX; Xing XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):228-235. PubMed ID: 32234181
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic Syndrome as a marker of cardiovascular events in hypertensives in primary prevention].
    Costa JA; Rodilla E; Cardona J; González C; Pascual JM
    Med Clin (Barc); 2012 Jul; 139(4):150-6. PubMed ID: 21813141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.
    Reboldi G; Verdecchia P; Saladini F; Pane M; Beilin LJ; Eguchi K; Imai Y; Kario K; Ohkubo T; Pierdomenico SD; Schwartz JE; Wing L; Palatini P
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):966-974. PubMed ID: 31169986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score.
    Oleksiak A; Kruk M; Lenarczyk E; Pawelec M; Rajska E; Wilkońska P; Dzielińska Z; Demkow M; Witkowski A; Pręgowski J; Kępka C; Rużyłło W
    Atherosclerosis; 2016 Mar; 246():57-62. PubMed ID: 26756971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin, cardiometabolic and other adverse outcomes: systematic review and meta-analyses of 48 published observational cohort studies involving 1,492,237 participants.
    Seidu S; Kunutsor SK; Khunti K
    Scand Cardiovasc J; 2020 Oct; 54(5):280-293. PubMed ID: 32378436
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases.
    Carriere C; Stolfo D; Baglio V; Gerloni R; Merlo M; Barbati G; Cannatà A; Biolo G; Sinagra G
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):536-545. PubMed ID: 30119097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.
    Djamali A; Singh T; Melamed ML; Stein JH; Aziz F; Parajuli S; Mohamed M; Garg N; Mandelbrot D; Wesson DE; Astor BC
    Am J Kidney Dis; 2019 Apr; 73(4):476-485. PubMed ID: 30704880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients.
    Perri L; Pastori D; Pignatelli P; Violi F; Loffredo L
    Int J Cardiol; 2015 Jan; 179():139-43. PubMed ID: 25464433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL8 is not associated with cardiovascular events but with all-cause mortality.
    Moreno Velásquez I; Gajulapuri A; Leander K; Berglund A; de Faire U; Gigante B
    BMC Cardiovasc Disord; 2019 Feb; 19(1):34. PubMed ID: 30717657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients.
    Zitt E; Kirsch AH; Haueis M; Strasak A; Neyer U; Mayer G; Rosenkranz AR
    Clin Nephrol; 2011 Apr; 75(4):309-18. PubMed ID: 21426885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.